p53 (TP53) antibody
Principal name
p53 (TP53) antibody
Alternative names for p53 (TP53) antibody
Cellular tumor antigen p53, Tumor suppressor p53, Phosphoprotein p53, NY-CO-13, FocusOn129
Selected pictures


SwissProt ID
P02340 (Mouse), P04637 (Human), P07193 (Xenla), P10360 (Chick), P10361 (Rat), P41685 (Felca), P51664 (Sheep), P67939 (Bovin), P79892 (Horse), Q29537 (Canfa), Q95330 (Rabit), Q9TUB2 (Pig), Q9WUR6 (Cavpo)
Ncbi ID
NP_000537.3, 9606, NP_000537, NP_035770, NP_001120705.1, NP_001120705, 10090, NP_001081567, NP_112251.2, NP_006149
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Paraffin Sections (P), Frozen Sections (C), Enzyme Immunoassay (E), Radioimmunoassay (R), Flow Cytometry (F), ELISA (detection) (E(detection)), Dot blot (Dot), ChIP assay (ChIP), Radial Immunodiffusion (RID), ELISA (capture) (E(capture))
Background of p53 (TP53) antibody
The 393 amino acid tumor suppressor phosphoprotein p53 plays a major role in the cellular response to DNA damage and other genomic aberrations. The activation of p53 can lead to either cell cycle arrest and DNA repair, or apoptosis. p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro. p53 can apparently be phosphorylated by ATM, ATR, and DNA-PK at Ser15; the phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and functional activation of p53 in response to DNA damage. The level of p53 protein is low in normal cells but increases following DNA damage or cellular stress. Mutations in the p53 gene are found in more than 50% of human cancers. p53 acts to arrest the cell cycle or induce apoptosis by regulating the transcription of specific genes. p53 can also initiate apoptosis through a direct signaling pathway. The p53 tumor suppressor gene encodes a transcription factor that contributes to several cellular activities that include apoptosis, transient growth arrest, and sustained growth arrest or senescence. Mutations within the p53 gene are found in about half of all human cancers. In cells that are functioning normally the MDM2 protein binds to p53 and maintains p53 at low levels by increasing its susceptibility to proteolysis by the 26S proteosome. A cell that undergoes stress loses the ability of MDM2 to bind to p53 and as a result p53 levels increase which then leads to cell cycle arrest or apoptosis. p53 induced cell cycle arrest or apoptosis can be achieved through transcriptional regulation of several genes including the cell cycle inhibitor p21, DNA repair gene GADD45, and the apoptotic inducer Bax. Besides MDM2 inactivation, p53 can also be functionally inactivated by mutation or binding to DNA tumor virus encoded proteins, such as SV40 large T antigen, Adenovirus E1B and papilloma virus E6 proteins.
General readings
1. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Lane DP: Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer 46, 839-844 (1990)
2. Bartek J, Bartkova J, Lukas J, Staskova Z, Vojtesek B, Lane DP: Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 169, 27-34 (1993)
3. Fisher CJ, Gillett CE, Vojtesek B, Barnes DM, Millis RR: Problems with p53 immunohistochemcal staining: the effect of fixation and variation in the methods of evaluation. Br J Cancer 60, 26-31 (1994)
4. Petersen G, Song D, Hügle-Dörr B, Oldenburg I, Bautz EKF: Mapping of linear epitopes recognized by monoclonal antibodies with genefragment phage display libraries. Mol Gen Genet 249, 425-431 (1995)
5. Stephen CW, Helminen P, Lane DP: Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibodypeptide interactions. J Mol Biol 248, 58-78 (1995)
6. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 58, 5-13 (1998)
7. Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX: Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma. Clin Cancer Res 7, 290-296 (2001)
8. Ohtake S, Cheng J, Ida H, Suzuki M, Ohshiro K, Zhang W, Saku T: Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by p53 immunohistochemistry. J Oral Pathol Med 31, 590-597 (2002)
9. Zarka TA, Han AC, Edelson MI, Rosenblum NG: Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: Potential tumor suppressor role for N-cadherin. Int J Gynecol Cancer 13, 240-243 (2003)
Antibodies
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| DB 002-0.1 |
p53 (TP53) (C-term) antibody | ||||||
![]() |
Rabbit | S11-K | Aff - Purified | Hu, Ms, Rt | E, IP, WB |
0.1 ml /
€550.00
|
|
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 002-0.05 |
p53 (TP53) (C-term) antibody | ||||||
![]() |
Rabbit | S11-K | Aff - Purified | Hu, Ms, Rt | E, IP, WB |
50 µl /
€310.00
|
|
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 026-0.1 |
p53 (TP53) (N-term) antibody | ||||||
![]() |
Rabbit | M26-A | Aff - Purified | P |
0.1 ml /
€270.00
|
||
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 026-0.2 |
p53 (TP53) (N-term) antibody | ||||||
![]() |
Rabbit | M26-A | Aff - Purified | P |
0.2 ml /
€410.00
|
||
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 026-0.5 |
p53 (TP53) (N-term) antibody | ||||||
![]() |
Rabbit | M26-A | Aff - Purified | P |
0.5 ml /
€460.00
|
||
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 026-1 |
p53 (TP53) (N-term) antibody | ||||||
![]() |
Rabbit | M26-A | Aff - Purified | P |
1 ml /
€660.00
|
||
| IgG | DB Biotech, spol. s r.o. | ||||||
| DB 1012 |
p53 (TP53) antibody | ||||||
![]() |
Rabbit | H21-E | FITC | Hu | F |
100 Tests /
€510.00
|
|
| IgG | DB Biotech, spol. s r.o. | ||||||
| 10442-1-AP |
p53 (TP53) antibody | ||||||
![]() |
Rabbit | Aff - Purified | Hu | E, WB |
0.15 ml /
€255.00
|
||
| IgG | ProteinTech Group, Inc. | ||||||
+2 additional images | |||||||
| 21891-1-AP |
p53 (TP53) antibody | ||||||
![]() |
Rabbit | Aff - Purified | Hu, Ms, Rt | E, P, WB |
0.15 ml /
€255.00
|
||
| IgG | ProteinTech Group, Inc. | ||||||
| AM00101PU-N |
p53 (TP53) pSer392 antibody | ||||||
![]() |
Mouse | 9F4 | Purified | Hu | E, WB |
0.1 mg /
€390.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
| AM00166PU-N |
p53 (TP53) antibody | ||||||
![]() |
Mouse | C6A5 | Purified | Hu, Ms, Rt | ICC/IF, IP, P, WB |
0.1 mg /
€370.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
| AM00484PU-N |
p53 (TP53) (Wild type + Mutant) (46-55) antibody | ||||||
![]() |
Mouse | Pab 1801 | Purified | Hu | IP, P, WB |
0.1 mg /
€410.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
| AM03100PU-N |
p53 (TP53) pSer392 antibody | ||||||
![]() |
Mouse | FP3.2 | Aff - Purified | Hu | P, WB |
0.1 mg /
€240.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
| AM05279PU-N |
p53 (TP53) (16-25) antibody | ||||||
![]() |
Mouse | X77 | Purified | Hu, Ms, Xen | E, IP, WB |
0.1 mg /
€300.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
| AM05327PU-N |
p53 (TP53) (371-380) antibody | ||||||
![]() |
Mouse | HR231 | Purified | Hu, Mky, Ms, Rt | C, E, IP, WB |
0.1 mg /
€300.00
|
|
| IgG2b | Acris Antibodies GmbH | ||||||
+1 additional image | |||||||
| AM05328PU-N |
p53 (TP53) (371-380) antibody | ||||||
![]() |
Mouse | Pab122 | Purified | Hst, Hu, Mky, Ms, Rt | F, ICC/IF, IP |
0.1 mg /
€300.00
|
|
| IgG2b | Acris Antibodies GmbH | ||||||
| AM06330SU-N |
p53 (TP53) antibody | ||||||
![]() |
Mouse | 4A8 | Ascites | Hu | P, WB |
0.1 ml /
€370.00
|
|
| IgG1 | Acris Antibodies GmbH | ||||||
+1 additional image | |||||||
| AM08294PU-N |
p53 (TP53) antibody | ||||||
![]() |
Mouse | n.a | Purified | Can, Hu, Ms, Rt | E, IP, P, WB |
50 µg /
€380.00
|
|
| IgG2a | Acris Antibodies GmbH | ||||||
| AM09102PU-N |
p53 (TP53) (Wild type + Mutant) (20-31) antibody | ||||||
![]() |
Mouse | Bp53-11 | Aff - Purified | Hu | C, E, ICC/IF, IP, P, WB |
25 µg /
€250.00
|
|
| IgG2a | Acris Antibodies GmbH | ||||||
| AM10034FC-N |
p53 (TP53) antibody | ||||||
![]() |
Mouse | P53221 | FITC | Hu | C, F, ICC/IF, P |
0.2 mg /
€330.00
|
|
| IgG2a | Acris Antibodies GmbH | ||||||









+2 additional images





